These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18332137)

  • 1. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
    Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
    J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.
    Lim JH; Stirling B; Derry J; Koga T; Jono H; Woo CH; Xu H; Bourne P; Ha UH; Ishinaga H; Xu H; Andalibi A; Feng XH; Zhu H; Huang Y; Zhang W; Weng X; Yan C; Yin Z; Briles DE; Davis RJ; Flavell RA; Li JD
    Immunity; 2007 Aug; 27(2):349-60. PubMed ID: 17723219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7.
    Yoshida H; Jono H; Kai H; Li JD
    J Biol Chem; 2005 Dec; 280(49):41111-21. PubMed ID: 16230348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2.
    Lim JH; Ha U; Sakai A; Woo CH; Kweon SM; Xu H; Li JD
    BMC Immunol; 2008 Jul; 9():40. PubMed ID: 18664270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae stabilizes tumor necrosis factor alpha mRNA through a pathway dependent on p38 MAPK but independent of Toll-like receptors.
    Mogensen TH; Berg RS; Ostergaard L; Paludan SR
    BMC Immunol; 2008 Sep; 9():52. PubMed ID: 18796140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
    Thuille N; Wachowicz K; Hermann-Kleiter N; Kaminski S; Fresser F; Lutz-Nicoladoni C; Leitges M; Thome M; Massoumi R; Baier G
    PLoS One; 2013; 8(1):e53709. PubMed ID: 23335970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway.
    Mikami F; Gu H; Jono H; Andalibi A; Kai H; Li JD
    J Biol Chem; 2005 Oct; 280(43):36185-94. PubMed ID: 16115866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinpocetine Suppresses
    Komatsu K; Nam DH; Lee JY; Yoneda G; Yan C; Li JD
    J Immunol; 2020 Feb; 204(4):933-942. PubMed ID: 31900337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
    Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
    J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYLD negatively regulates nontypeable Haemophilus influenzae-induced IL-8 expression via phosphatase MKP-1-dependent inhibition of ERK.
    Wang WY; Komatsu K; Huang Y; Wu J; Zhang W; Lee JY; Miyata M; Xu H; Li JD
    PLoS One; 2014; 9(11):e112516. PubMed ID: 25389768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt.
    Lim JH; Jono H; Komatsu K; Woo CH; Lee J; Miyata M; Matsuno T; Xu X; Huang Y; Zhang W; Park SH; Kim YI; Choi YD; Shen H; Heo KS; Xu H; Bourne P; Koga T; Xu H; Yan C; Wang B; Chen LF; Feng XH; Li JD
    Nat Commun; 2012 Apr; 3():771. PubMed ID: 22491319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4 mediates pneumolysin-induced ATF3 expression through the JNK/p38 pathway in Streptococcus pneumoniae-infected RAW 264.7 cells.
    Nguyen CT; Kim EH; Luong TT; Pyo S; Rhee DK
    Mol Cells; 2015 Jan; 38(1):58-64. PubMed ID: 25518930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway.
    Ha UH; Lim JH; Kim HJ; Wu W; Jin S; Xu H; Li JD
    J Biol Chem; 2008 Nov; 283(45):30624-31. PubMed ID: 18782768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacterium, nontypeable Haemophilus influenzae, enhances host antiviral response by inducing Toll-like receptor 7 expression: evidence for negative regulation of host anti-viral response by CYLD.
    Sakai A; Koga T; Lim JH; Jono H; Harada K; Szymanski E; Xu H; Kai H; Li JD
    FEBS J; 2007 Jul; 274(14):3655-3668. PubMed ID: 17608805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates
    Matsuyama S; Komatsu K; Lee BC; Tasaki Y; Miyata M; Xu H; Shuto T; Kai H; Li JD
    J Immunol; 2022 Oct; 209(8):1532-1544. PubMed ID: 36165197
    [No Abstract]   [Full Text] [Related]  

  • 17. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
    Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
    J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.
    Nikolaou K; Tsagaratou A; Eftychi C; Kollias G; Mosialos G; Talianidis I
    Cancer Cell; 2012 Jun; 21(6):738-50. PubMed ID: 22698400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD.
    Zhang J; Ou J; Wan X
    Exp Cell Res; 2019 Oct; 383(1):111497. PubMed ID: 31301291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.